van Vollenhoven, R., Harju, A., Brannemark, S., & Klareskog, L. (2003). Treatment with infliximab (Remicade) when etanercept (Enbrel) has failed or vice versa: Data from the STURE registry showing that switching tumour necrosis factor α blockers can make sense.
Citação norma Chicagovan Vollenhoven, R., A. Harju, S. Brannemark, and L. Klareskog. Treatment With Infliximab (Remicade) When Etanercept (Enbrel) Has Failed or Vice Versa: Data From the STURE Registry Showing That Switching Tumour Necrosis Factor α Blockers Can Make Sense. 2003.
Citação norma MLAvan Vollenhoven, R., A. Harju, S. Brannemark, and L. Klareskog. Treatment With Infliximab (Remicade) When Etanercept (Enbrel) Has Failed or Vice Versa: Data From the STURE Registry Showing That Switching Tumour Necrosis Factor α Blockers Can Make Sense. 2003.